HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.

Abstract
Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is an inflammatory cytokine that modulates several biological responses by inducing chemokines and proinflammatory cytokines. We hypothesized that TWEAK could promote secretion of IL-17, an amplifier of inflammatory arthritis. To test this, we investigated the capacity of TWEAK to induce IL-17 production in T cells via the fibroblast growth factor-inducible gene 14 (Fn14, also known as TWEAK receptor) signal pathway in rheumatoid arthritis (RA). Fn14 and IL-17 were highly expressed in arthritic tissues of collagen-induced arthritis (CIA) mice. TWEAK induced production of IL-17 alone and synergistically with lipopolysaccharide. In naïve murine T cells, TWEAK promoted Th17 differentiation. The expression of Fn14 was predominant in Th17 cells. TWEAK and IL-17 concentrations were significantly higher in synovial fluid and serum in RA patients than OA patients. In addition, we identified CD4(+)IL-17(+)Fn14(+) cells in synovium from RA patients. TWEAK promoted IL-17 production synergistically with IL-23 or IL-21 and blockade of Fn14 with Fn14-Fc suppressed Th17 differentiation. Conversely, this treatment enhanced Treg differentiation. These results suggest that TWEAK induces IL-17 production and may be a therapeutic target in the treatment of RA.
AuthorsJin-Sil Park, Mi-Kyung Park, Seon-Yeong Lee, Hye-Jwa Oh, Mi-Ae Lim, Woo-Tae Cho, Eun-Kyung Kim, Ji-Hyeon Ju, Young-Woo Park, Sung-Hwan Park, Mi-La Cho, Ho-Youn Kim
JournalCytokine (Cytokine) Vol. 60 Issue 1 Pg. 143-9 (Oct 2012) ISSN: 1096-0023 [Electronic] England
PMID22819243 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Cytokine TWEAK
  • Interleukin-17
  • Interleukin-23
  • Interleukins
  • Lipopolysaccharides
  • Receptors, Tumor Necrosis Factor
  • Recombinant Proteins
  • TNFRSF12A protein, human
  • TNFSF12 protein, human
  • TWEAK Receptor
  • Tnfrsf12a protein, mouse
  • Tumor Necrosis Factors
  • interleukin-21
Topics
  • Animals
  • Arthritis, Experimental (genetics, metabolism)
  • Arthritis, Rheumatoid (blood, genetics, metabolism)
  • CD4-Positive T-Lymphocytes (drug effects, metabolism)
  • Cells, Cultured
  • Cytokine TWEAK
  • Drug Synergism
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression (drug effects)
  • Interleukin-17 (blood, genetics, metabolism)
  • Interleukin-23 (pharmacology)
  • Interleukins (pharmacology)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Mice
  • Mice, Inbred DBA
  • Osteoarthritis (blood, genetics, metabolism)
  • Receptors, Tumor Necrosis Factor (metabolism)
  • Recombinant Proteins (pharmacology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spleen (cytology, metabolism)
  • TWEAK Receptor
  • Tumor Necrosis Factors (blood, genetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: